Apimeds Pharmaceuticals US Inc
AMEX:APUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
US |
Shareholder Yield
Current shareholder yield for APUS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
APUS Price
Apimeds Pharmaceuticals US Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -72% |
| Market Capitalization | 23.6m USD |
| Shares Outstanding | 12 580 000 |
| Percentage of Shares Shorted |
N/A
|
APUS Return Decomposition
Main factors of price return
Stock Splits
APUS's latest stock split occurred on Mar 26, 2026
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, APUS traded at 0.175 per share. Afterward, the share price was about 1.63.
The adjusted shares began trading on Mar 26, 2026. This was the only stock split in APUS's history.
